HONY Capital

HONY Capital (弘毅资本 / 弘毅投资) is a Chinese private-equity fund with a long track record in buyouts and growth capital. The firm was an early mover in domestic PE-led acquisitions, notably including the restructuring of China Glass as far back as the post-WTO era, per a 2022 暗涌Waves retrospective on Chinese buyout waves . It has since remained active across consumer and healthcare sectors, backing companies such as salad chain 好色派沙拉 alongside IDG and FreeS in 2017 , and more recently participating in the $68.7 million founding and extension rounds for Aikelian Biotechnology in 2025–2026 alongside Sequoia China, 5Y Capital and others . Cao Yonggang (曹永刚) is identified as a representative figure at the firm . elsewheres corpus does not include more recent fund-scale or strategy updates beyond this period.